Compare MLGO & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLGO | TELA |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.9M | 41.3M |
| IPO Year | 2020 | 2019 |
| Metric | MLGO | TELA |
|---|---|---|
| Price | $4.05 | $0.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 30.1K | ★ 73.5K |
| Earning Date | 04-01-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 37.59 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $87,132,230.00 | $80,275,000.00 |
| Revenue This Year | N/A | $10.23 |
| Revenue Next Year | N/A | $14.26 |
| P/E Ratio | $0.91 | ★ N/A |
| Revenue Growth | 6.21 | ★ 15.84 |
| 52 Week Low | $3.02 | $0.50 |
| 52 Week High | $13.60 | $2.14 |
| Indicator | MLGO | TELA |
|---|---|---|
| Relative Strength Index (RSI) | 45.80 | 64.79 |
| Support Level | $3.95 | $0.78 |
| Resistance Level | $4.44 | $0.95 |
| Average True Range (ATR) | 0.21 | 0.07 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 23.66 | 84.39 |
MicroAlgo Inc is engaged in the development and application of bespoke central processing algorithms and provides solutions by integrating these algorithms with software or hardware, or both, to streamline digital services. Its services include algorithm optimization, accelerating computing power without hardware upgrades, lightweight data processing, and data intelligence services. Its technology and solutions are mainly in internet multimedia video advertising, where it provides advertising distribution solutions, software services, comprehensive solutions for enterprise customers, and intelligent chips solutions. It derives revenue from central processing algorithm services for internet advertisement and intelligent chips and services, with maximum revenue generated from Mainland PRC.
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.